Results 251 to 260 of about 6,262,057 (305)

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of the study is to describe the use of immune checkpoint inhibitors (ICIs) for the treatment of cancer in Scotland. Methods The retrospective observational cohort study included patients aged 18 years or older who commenced treatment with an ICI in Scotland between 1 January 2018 and 31 December 2024.
Tanja Mueller, Christine Crearie, Liya Lu, Jiafeng Pan, Fraser N. Sneden, David Martin, Amanj Kurdi, Catherine S. Thomson, Julie Clarke, Marion Bennie   +9 more
wiley   +1 more source

Digital financial inclusion and comprehensive multilevel medical insurance system in China. [PDF]

Front Public Health
Liu Z, Wu X, Chen X, Qin C, Qiu Z, Fang Z, Yao L.   +6 more
europepmc   +1 more source

Health technology assessment and medical insurance access for rare disease drugs in China: A policy review with quantitative insights from publicly available data. [PDF]

Intractable Rare Dis Res
Ai D, Sui B, Duan C, Liu Z, Zhang F, Zhao K.   +5 more
europepmc   +1 more source

China's universal medical insurance scheme: progress and perspectives. [PDF]

BMC Glob Public Health
Zhang J, Zhao D, Zhang X.
europepmc   +1 more source

Medical insurance integration and rural-urban benefit disparities, 2006-2021: evidence from quasi-natural experiments in China. [PDF]

BMJ Open
Yan J.
europepmc   +1 more source

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source

Analysis of the role of medical insurance in the "Health shocks-consumption upgrading" model: evidence from China. [PDF]

Health Econ Rev
Hu Q, Wang E, Zhu M.
europepmc   +1 more source

Importancia de la exploración médica en la ejecución de las tareas de la defensa del país

Revista Habanera de Ciencias Médicas
Yllimany Lafargue Oliva
doaj  

The insurance value of medical innovation [PDF]

Journal of Public Economics, 2017
Abstract Economists think of medical innovation as a valuable but risky good, producing health benefits but increasing financial risk for consumers and healthcare payers. This perspective overlooks how innovation can lower physical risks borne by healthy patients facing the prospect of future disease.
Lakdawalla, Darius, Malani, Anup, Reif, Julian   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Distribution of medical insurance in China

Social Science & Medicine, 1995
This paper investigates factors related to the distribution of medical insurance coverage in China, using information from an eight-province household survey of almost 16,000 individuals, conducted in 1989. Results of bivariate analyses show that medical insurance coverage, defined very broadly, varies considerably by individual and regional ...
G, Henderson, S, Jin, J, Akin, X, Li, J, Wang, H, Ma, Y, He, X, Zhang, Y, Chang, K, Ge   +9 more
openaire   +2 more sources